Biotechnology
QURE
67.69
price down icon0.25%   -0.17
 

Uniqure N V (QURE)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$67.86
Offen:
$68
24-Stunden-Volumen:
889.93K
Relative Volume:
0.28
Marktkapitalisierung:
$3.71B
Einnahmen:
$14.34M
Nettoeinkommen (Verlust:
$-199.00M
KGV:
-17.27
EPS:
-3.92
Netto-Cashflow:
$-183.51M
1W Leistung:
+10.95%
1M Leistung:
+15.97%
6M Leistung:
+358.60%
1J Leistung:
+1,083%
1-Tages-Spanne:
Value
$66.00
$68.62
1-Wochen-Bereich:
Value
$61.30
$71.50
52-Wochen-Spanne:
Value
$5.35
$71.50

Uniqure N V Stock (QURE) Company Profile

Name
Firmenname
Uniqure N V
Name
Sektor
Healthcare (1135)
Name
Branche
Biotechnology (635)
Name
Telefon
1-339-970-7000
Name
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Name
Mitarbeiter
209
Name
Twitter
@uniQure_NV
Name
Nächster Verdiensttermin
2025-10-31
Name
Neueste SEC-Einreichungen
Name
QURE's Discussions on Twitter

Vergleichen Sie QURE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
QURE
Uniqure N V
 67.69 4.18B 14.34M -199.00M -183.51M -3.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 456.04 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
 818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 189.60 41.29B 398.11M -1.03B -868.57M -5.7032

Uniqure N V Stock (QURE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-14 Hochstufung Mizuho Neutral → Outperform
2025-04-01 Fortgesetzt Chardan Capital Markets Buy
2024-12-10 Hochstufung Raymond James Outperform → Strong Buy
2024-10-10 Fortgesetzt Raymond James Outperform
2024-02-29 Herabstufung Goldman Buy → Neutral
2023-12-19 Herabstufung Mizuho Buy → Neutral
2022-03-17 Hochstufung UBS Neutral → Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-21 Eingeleitet UBS Neutral
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-01 Hochstufung Mizuho Neutral → Buy
2021-01-07 Hochstufung Guggenheim Neutral → Buy
2020-11-24 Eingeleitet H.C. Wainwright Buy
2020-11-11 Eingeleitet Berenberg Buy
2020-11-09 Eingeleitet Jefferies Buy
2020-11-04 Eingeleitet Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet RBC Capital Mkts Outperform
2020-08-25 Eingeleitet Raymond James Strong Buy
2020-07-31 Hochstufung Robert W. Baird Neutral → Outperform
2020-06-25 Herabstufung Mizuho Buy → Neutral
2020-06-25 Herabstufung Robert W. Baird Outperform → Neutral
2020-06-25 Herabstufung Wells Fargo Overweight → Equal Weight
2019-12-03 Eingeleitet Cowen Outperform
2019-12-03 Eingeleitet Goldman Buy
2019-11-05 Eingeleitet Credit Suisse Outperform
2019-10-11 Eingeleitet Stifel Buy
2019-09-25 Eingeleitet Bernstein Outperform
2019-09-12 Eingeleitet Mizuho Buy
2019-07-30 Herabstufung Guggenheim Buy → Neutral
2019-07-08 Bestätigt Cantor Fitzgerald Overweight
2019-04-12 Eingeleitet Piper Jaffray Overweight
2019-03-29 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Uniqure N V Aktie (QURE) Neueste Nachrichten

pulisher
05:24 AM

Can uniQure N.V. stock hit record highs againJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

05:24 AM
pulisher
02:24 AM

Risk adjusted return profile for uniQure N.V. analyzedQuarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com

02:24 AM
pulisher
02:04 AM

Can uniQure N.V. stock hit analyst price targets2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com

02:04 AM
pulisher
01:11 AM

What data driven models say about uniQure N.V.’s futureEarnings Performance Report & Free Community Supported Trade Ideas - newser.com

01:11 AM
pulisher
Oct 31, 2025

uniQure N.V. stock outlook for YEARPortfolio Update Summary & Smart Investment Allocation Insights - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is uniQure N.V. stock trading at a premium valuation2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is uniQure N.V. stock a bargain at current levelsJuly 2025 Levels & Risk Managed Investment Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What catalysts could drive uniQure N.V. stock higherTrade Analysis Report & Low Drawdown Investment Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to read the order book for uniQure N.V.Bond Market & Safe Capital Investment Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is uniQure N.V. (UQ1) stock a top dividend aristocrat candidate2025 Market Overview & Consistent Income Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Applying Wyckoff theory to uniQure N.V. stockRate Hike & High Accuracy Buy Signal Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using Bollinger Bands to evaluate uniQure N.V.Bear Alert & Low Risk High Win Rate Stock Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will uniQure N.V. stock benefit from automationJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

How analysts rate uniQure N.V. stock todayLayoff News & Reliable Breakout Forecasts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How institutional buying supports uniQure N.V. stock2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com

Oct 30, 2025
pulisher
Oct 28, 2025

How uniQure N.V. stock reacts to job market dataJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

uniQure (NASDAQ:QURE) Hits New 1-Year HighShould You Buy? - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Uniqure stock hits 52-week high at 65.19 USD By Investing.com - Investing.com Australia

Oct 28, 2025
pulisher
Oct 28, 2025

uniQure (QURE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Oct 28, 2025
pulisher
Oct 27, 2025

Why uniQure N.V. stock is rated strong buyPortfolio Growth Summary & Fast Entry High Yield Tips - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

A Look at uniQure (QURE) Valuation Following Breakthrough Huntington’s Data and Rising Regulatory Optimism - simplywall.st

Oct 27, 2025

Finanzdaten der Uniqure N V-Aktie (QURE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Uniqure N V-Aktie (QURE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Kapusta Matthew C
CEO, Managing Director
Sep 24 '25
Sale
41.46
226,316
9,382,473
651,454
KLEMT CHRISTIAN
Chief Financial Officer
Sep 26 '25
Option Exercise
5.37
15,000
80,550
232,730
KLEMT CHRISTIAN
Chief Financial Officer
Sep 24 '25
Option Exercise
13.03
3,000
39,090
220,730
KLEMT CHRISTIAN
Chief Financial Officer
Sep 26 '25
Sale
55.00
15,000
825,000
217,730
KLEMT CHRISTIAN
Chief Financial Officer
Sep 24 '25
Sale
40.04
3,000
120,120
217,730

Ähnlich wie QURE

biotechnology RPRX
$37.54
price up icon 1.62%
biotechnology INCY
$93.48
price up icon 0.96%
biotechnology GMAB
$28.61
price down icon 0.21%
biotechnology BNTX
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
biotechnology INSM
$189.60
price down icon 2.38%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):